Parkman Healthcare Partners as of March 31, 2022
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 80 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Irhythm Technologies (IRTC) | 4.8 | $16M | 104k | 157.47 | |
United Therapeutics Corporation (UTHR) | 3.9 | $13M | 74k | 179.42 | |
UnitedHealth (UNH) | 3.8 | $13M | 25k | 509.97 | |
Seagen | 3.6 | $12M | 86k | 144.05 | |
Immunic (IMUX) | 3.6 | $12M | 1.1M | 11.30 | |
Tenet Healthcare Corp Com New (THC) | 3.5 | $12M | 139k | 85.96 | |
Iqvia Holdings (IQV) | 3.4 | $12M | 50k | 231.20 | |
Aclaris Therapeutics (ACRS) | 3.4 | $12M | 668k | 17.24 | |
Danaher Corporation (DHR) | 3.2 | $11M | 37k | 293.33 | |
Xenon Pharmaceuticals (XENE) | 2.7 | $9.3M | 304k | 30.57 | |
R1 Rcm | 2.7 | $9.2M | 343k | 26.76 | |
Alnylam Pharmaceuticals (ALNY) | 2.6 | $8.8M | 54k | 163.29 | |
Catalent (CTLT) | 2.6 | $8.8M | 79k | 110.91 | |
CVS Caremark Corporation (CVS) | 2.5 | $8.7M | 86k | 101.21 | |
Peregrine Pharmaceuticals (CDMO) | 2.4 | $8.3M | 408k | 20.37 | |
Cooper Cos Com New | 2.4 | $8.2M | 20k | 417.62 | |
BioCryst Pharmaceuticals (BCRX) | 2.3 | $7.8M | 477k | 16.26 | |
Abbvie (ABBV) | 2.2 | $7.4M | 46k | 162.10 | |
Dex (DXCM) | 1.9 | $6.5M | 13k | 511.58 | |
Neurocrine Biosciences (NBIX) | 1.7 | $5.9M | 63k | 93.75 | |
Codexis (CDXS) | 1.6 | $5.5M | 268k | 20.62 | |
Avantor (AVTR) | 1.6 | $5.4M | 158k | 33.82 | |
Natera (NTRA) | 1.5 | $5.3M | 130k | 40.68 | |
Arcus Biosciences Incorporated (RCUS) | 1.5 | $5.3M | 167k | 31.56 | |
Alphatec Hldgs Com New (ATEC) | 1.5 | $5.2M | 452k | 11.50 | |
IDEXX Laboratories (IDXX) | 1.5 | $5.1M | 9.4k | 547.08 | |
Apollo Endosurgery | 1.4 | $4.9M | 810k | 6.05 | |
Sierra Oncology Com New | 1.4 | $4.9M | 152k | 32.05 | |
Teleflex Incorporated (TFX) | 1.3 | $4.4M | 13k | 354.80 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 1.3 | $4.4M | 121k | 36.34 | |
Schrodinger (SDGR) | 1.2 | $4.0M | 116k | 34.12 | |
Keros Therapeutics (KROS) | 1.2 | $4.0M | 73k | 54.38 | |
Harvard Bioscience (HBIO) | 1.2 | $3.9M | 634k | 6.21 | |
Fulcrum Therapeutics (FULC) | 1.1 | $3.9M | 165k | 23.65 | |
Outset Med (OM) | 1.1 | $3.7M | 82k | 45.40 | |
Supernus Pharmaceuticals (SUPN) | 1.0 | $3.5M | 109k | 32.32 | |
Insulet Corporation (PODD) | 1.0 | $3.4M | 13k | 266.36 | |
908 Devices (MASS) | 1.0 | $3.3M | 175k | 19.01 | |
Biosante Pharmaceuticals (ANIP) | 0.9 | $3.0M | 108k | 28.11 | |
Performant Finl (PFMT) | 0.9 | $3.0M | 957k | 3.11 | |
Charles River Laboratories (CRL) | 0.8 | $2.8M | 10k | 284.00 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.8 | $2.7M | 77k | 35.28 | |
Imago Biosciences | 0.8 | $2.7M | 140k | 19.27 | |
Bicycle Therapeutics Sponsored Ads (BCYC) | 0.7 | $2.5M | 57k | 43.88 | |
Mannkind Corp Com New (MNKD) | 0.7 | $2.5M | 675k | 3.68 | |
Health Catalyst (HCAT) | 0.6 | $2.1M | 80k | 26.13 | |
Madrigal Pharmaceuticals (MDGL) | 0.6 | $2.0M | 20k | 98.12 | |
Repro-Med Systems (KRMD) | 0.6 | $1.9M | 673k | 2.86 | |
Altimmune Com New (ALT) | 0.6 | $1.9M | 310k | 6.09 | |
Gossamer Bio (GOSS) | 0.5 | $1.7M | 200k | 8.68 | |
Veracyte (VCYT) | 0.5 | $1.7M | 61k | 27.57 | |
AtriCure (ATRC) | 0.5 | $1.7M | 25k | 65.66 | |
Akoya Biosciences (AKYA) | 0.5 | $1.7M | 150k | 10.99 | |
Alpha Teknova (TKNO) | 0.5 | $1.6M | 120k | 13.81 | |
Sutro Biopharma (STRO) | 0.5 | $1.6M | 200k | 8.22 | |
Plus Therapeutics Com New | 0.4 | $1.5M | 1.5M | 1.00 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.4 | $1.4M | 25k | 55.31 | |
Landec Corporation (LFCR) | 0.4 | $1.3M | 115k | 11.58 | |
Concert Pharmaceuticals I equity | 0.4 | $1.3M | 377k | 3.37 | |
Tela Bio (TELA) | 0.4 | $1.3M | 109k | 11.63 | |
Mirati Therapeutics | 0.4 | $1.3M | 15k | 82.24 | |
Recro Pharma (SCTL) | 0.4 | $1.2M | 672k | 1.80 | |
Sientra | 0.3 | $1.2M | 532k | 2.22 | |
Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.3 | $1.2M | 118k | 9.94 | |
Forma Therapeutics Hldgs SHS | 0.3 | $1.2M | 124k | 9.30 | |
Cti Biopharma | 0.3 | $1.1M | 225k | 4.67 | |
Axogen (AXGN) | 0.3 | $1.0M | 129k | 7.94 | |
Anaptysbio Inc Common (ANAB) | 0.3 | $922k | 37k | 24.73 | |
Phathom Pharmaceuticals (PHAT) | 0.3 | $892k | 66k | 13.61 | |
Allakos (ALLK) | 0.3 | $867k | 152k | 5.70 | |
Zymeworks | 0.2 | $781k | 119k | 6.55 | |
Opiant Pharmaceuticals | 0.2 | $697k | 33k | 21.41 | |
Mirum Pharmaceuticals (MIRM) | 0.2 | $668k | 30k | 22.01 | |
Surface Oncology | 0.2 | $615k | 209k | 2.94 | |
Biolinerx Sponsored Ads (BLRX) | 0.1 | $463k | 271k | 1.71 | |
Eiger Biopharmaceuticals | 0.1 | $415k | 50k | 8.30 | |
Rocket Pharmaceuticals (RCKT) | 0.1 | $401k | 25k | 15.85 | |
Molecular Templates | 0.1 | $358k | 104k | 3.45 | |
Nurix Therapeutics (NRIX) | 0.1 | $289k | 21k | 13.99 | |
Verastem | 0.1 | $269k | 191k | 1.41 |